Holen Sie sich die Stockscreener-App
1.11
0.00%
0.00
Schlusskurs vom Vortag:
$1.11
Offen:
$1.1108
24-Stunden-Volumen:
22,872
Relative Volume:
0.01
Marktkapitalisierung:
$16.80M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-7.78M
KGV:
-1.0729
EPS:
-1.0346
Netto-Cashflow:
$-7.49M
1W Leistung:
+0.00%
1M Leistung:
+13.46%
6M Leistung:
-13.28%
1J Leistung:
-47.39%
1-Tages-Spanne:
$1.0958
$1.14
1-Wochen-Bereich:
$1.06
$1.14
52-Wochen-Spanne:
$0.75
$2.29
Biocardia Inc Stock (BCDA) Company Profile
Firmenname
Biocardia Inc
Sektor
Branche
Telefon
650-226-0123
Adresse
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs PSNYW, GOODO, SHMD, CHAD, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.29 | 773.76M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.37 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.315 | 220.96M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.08 | 197.39M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
46.59 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-16 | Herabstufung | Dawson James | Buy → Neutral |
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
Why Did BCDA Stock Surge More Than 50% Today? - Stocktwits
BioCardia CEO Peter Altman buys 800 shares for $872 - Bitget
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia (BCDA) CEO adds 800 shares in open-market buy - Stock Titan
BioCardia Inc. Warrant (BCDAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DaySmart Beta Flow - vinanet.vn
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com Nigeria
BioCardia Advances Helix Catheter Toward De Novo Approval - TipRanks
BioCardia Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
BioCardia Received Notice of Noncompliance - TradingView
BioCardia’s Q2 2026 Update Keeps the Regulatory Story Alive, but Capital Still Drives the Risk - AlphaStreet
BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022 - Bitget
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BCDA Q2 2026 Earnings: EPS Surprise of 29.19% Narrows Losses as Shares Climb 4.82%Estimate Revision Count - vinanet.vn
BioCardia (BCDA) CEO buys 5,400 shares in open market - stocktitan.net
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceIceberg Order - vinanet.vn
BCDA Q2 2026 Earnings: Narrower-than-Expected Loss Drives Shares Up 4.82%Earnings Revision Upgrade - vinanet.vn
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,748 in company stock - Investing.com
BioCardia (BCDA) CEO Peter Altman purchases 1,900 shares at $0.92 average price - Stock Titan
BioCardia (BCDA) Holds at $0.88 as Range-Bound Trading PersistsTriple Top - vinanet.vn
BioCardia (BCDA) Drops 5.6% to $0.88 as Micro-Cap Biotech Tests Support LevelInsider Buying Alerts - vinanet.vn
BioCardia (BCDA) Advances Regulatory Pathway, Faces High Price-t - GuruFocus
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ... - Yahoo! Finance Canada
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulat - GuruFocus
BioCardia, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BioCardia Q2 loss narrows 67.5% YoY; regulatory milestones advance - scanx.trade
BCDA: Regulatory milestones and strong cash position support major market entry for cardiac therapies - TradingView
Earnings call transcript: BioCardia posts q2 2026 loss beat, shares rise after hours - Investing.com
Is BioCardia Inc (BCDA) Facing Financial Challenges After Q2 Ear - GuruFocus
BioCardia reports Q2 2026 net loss narrows to $1.6M; cash $4.1M with runway into 2027 - TradingView
BioCardia Reports Q2 2026 Net Loss of $1.6 Million - Quiver Quantitative
BioCardia (BCDA) Q2 2026 Earnings Call Transcript - The Globe and Mail
BCDA: Regulatory progress, clinical advances, and improved financials position for late 2026 submissions - TradingView
BioCardia, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results - The Manila Times
BRIEF-BioCardia, Inc. Q2 Net Income USD -1.613 Million - tradingview.com
BioCardia (BCDA.US) will release its earnings report before market open on August 12. - Moomoo
BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioCardia, Inc. Revenue Breakdown – NASDAQ:BCDA - TradingView
BioCardia Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
BioCardia Inc (BCDA) Stock News Today - TradingKey
Insiders In BioCardia Still Down 21% On US$1.08m Investment - simplywall.st
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 - The Manila Times
BioCardia to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 12 Conference Call - Quiver Quantitative
BioCardia Sets Live Webcast for Q2 Results on Aug. 12 - Stock Titan
BCDA Q2'26 Earnings: revenue estimate is 0 USD - TradingView
BioCardia (BCDA) Slips 0.5% to $0.82 as Shares Hold Above Key SupportPCR Extreme - vinanet.vn
BioCardia (BCDA) Q1 2026 Earnings: Wider EPS Loss of $0.21 Misses Estimates, Yet Stock Climbs 5.04%Earnings Outlook Update - dars.gov.et
BioCardia Inc. (BCDA) Q1 2026 Earnings: EPS Miss Magnifies Loss Amid Pre-Revenue StageCEO Earnings Statement - dars.gov.et
Finanzdaten der Biocardia Inc-Aktie (BCDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biocardia Inc-Aktie (BCDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO |
Aug 17 '26 |
Buy |
0.93 |
5,400 |
5,022 |
381,115 |
| Altman Peter | President and CEO |
Aug 13 '26 |
Buy |
0.92 |
1,900 |
1,748 |
375,785 |
| Altman Peter | President and CEO |
Jul 29 '26 |
Buy |
0.78 |
5,000 |
3,900 |
373,885 |
| Altman Peter | President and CEO |
Jul 17 '26 |
Buy |
0.83 |
500 |
415 |
368,885 |
| Altman Peter | President and CEO |
Jul 14 '26 |
Buy |
0.88 |
2,800 |
2,464 |
366,885 |
| Altman Peter | President and CEO |
Jul 15 '26 |
Buy |
0.86 |
1,500 |
1,290 |
368,385 |
| Altman Peter | President and CEO |
Jul 08 '26 |
Buy |
0.97 |
5,500 |
5,335 |
367,485 |
| Altman Peter | President and CEO |
Jul 10 '26 |
Buy |
0.94 |
1,000 |
940 |
369,485 |
| Altman Peter | President and CEO |
Jul 09 '26 |
Buy |
0.90 |
1,000 |
900 |
368,485 |
| Altman Peter | President and CEO |
Jul 08 '26 |
Buy |
0.96 |
5,400 |
5,208 |
361,985 |
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):